Filing metadata

Accession number
0001209191-20-031869
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
May 22, 2020
Reporting period
May 20, 2020
Description
Insider transaction

Explore SEC Filings Hub